SpyGlass Pharma
SGP21.2151.90% ( +0.395 )
SpyGlass Pharma (SGP)
SpyGlass Pharma, Inc. operates as a biopharmaceutical company that provides treatment and drug delivery for patients living with chronic eye conditions. The com...
- Open
- 21.060
- High
- 21.580
- Low
- 20.945
- Prev. Close
- 20.820
- Volume
- 26.88K
- Turnover
- 570.94K
- Avg Price
- 21.238
- Bid/Ask Ratio
- --
- Amplitude
- 3.05%
- 52wk High
- 32.440
- Volume Ratio
- 0.66
- Turnover Ratio
- 0.41%
SpyGlass Pharma Analyst Rating
View MoreForecast & Rating
Jun 10, 2026Price forecast
$45.00112.11%
Forecast & RatingStrong buy
5analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Global Report · Jul 9 at 09:03 PM
Market Orphans or Hidden Gems? Why These 9 Stocks Are Lumped Together in 2026
- Global Report · Jul 9 at 05:03 AM
Cross-Sector Rotation: AI Monetization Accelerates as Biotech and ADRs Hit Key Milestones
- Global Report · Jul 8 at 10:32 PM
USD 172.5M Raised and Massive Ethereum Buys: Broad US Equities Accelerate Capital Shifts
- Earnings Watch · May 14 at 03:44 PM
SpyGlass Pharma | 10-Q: FY2026 Q1 Revenue: USD 0
- Market Beat · Apr 13 at 01:39 PM
Spyglass Pharma (NASDAQ:SGP) Stock Price Up 8.6% - Here's What Happened
- benzinga_article · Mar 27 at 10:25 AM
SpyGlass Pharma shares are trading lower after the company reported a year-over-year decrease in Q4 financial results.
